Investor insights
Sectors invested in
Funding rounds participated in
$25M sweet spot round size
Most of their 98 investments are in rounds between $54M and $115M
Investor type
Basic info
Industry
Sectors
Date founded
2016
Investments made
Tentarix Biotherapeutics, Inc. raised $35M on September 6, 2023
Investors: Versant Ventures, Gilead Sciences, Amplitude Ventures and Samsara BioCapital
Septerna raised $150M on July 11, 2023
Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, Woodline Partners LP, RA Capital Management, L.P., Soleus Capital Management, L.P., Logos Global Management, LP, Vertex Ventures HC and Samsara BioCapital
SpyGlass Pharma, Inc. raised $90M on July 10, 2023
Investors: Vensana Capital, Vertex Ventures HC, RA Capital Management, L.P. and Samsara BioCapital
Undisclosed raised $200M on June 8, 2023
Investors: TCG X, Omega Funds, OrbiMed Advisors, Enavate Sciences, Decheng Capital, Wellington Management and Samsara BioCapital
Lyra Therapeutics raised $50M on May 26, 2023
Investors: Armistice Capital LLC, Woodline Partners LP, Surveyor Capital, Perceptive Advisors and Samsara BioCapital
OnKure Therapeutics raised $54M on May 23, 2023
Investors: Surveyor Capital, Acorn Bioventures, Perceptive Advisors and Samsara BioCapital
CARGO Therapeutics raised $200M on March 1, 2023
Investors: Nextech Invest, Perceptive Advisors, Red Tree Venture Capital, RTW Investments, LP, T. Rowe Price, Wellington Management, Third Rock Ventures and Samsara BioCapital
Palvella Therapeutics raised $38M on January 5, 2023
Investors: Nolan Capital, Inc., Gore Range Capital, -, Agent Capital, BioAdvance and Samsara BioCapital
Alpha-9 Theranostics Inc. raised $75M on December 14, 2022
Investors: Nextech Invest, Longitude Capital, Quark Venture and Samsara BioCapital
Enlaza Therapeutics raised $61M on October 12, 2022
Investors: Avalon Venture, Lightspeed Venture Partners and Samsara BioCapital